Literature DB >> 6202102

Some biological features of Proteus bacilli. 2. Haemolytic activities of Proteus mirabilis and Proteus vulgaris strains.

K Kotelko, W Kaca, A Rózalski, M Deka.   

Abstract

The haemolytic activities of Proteus mirabilis and P. vulgaris strains were studied under different conditions. No filterable alpha haemolysin could be detected in P. mirabilis uropathogens provided from patients with urinary tract infections. Together with the results presented in the accompanying paper, in which three clinical isolates with temporary ability to produce a soluble haemolysin were described, the occurrence of alpha haemolytic P. mirabilis isolates did not exceed 3%. Cell bound beta haemolysin is present in nearly 35% of P. mirabilis urinary strains. Another kind of haemolytic activity was observed when P. mirabilis and P. vulgaris strains were grown in liquid media supplemented with erythrocytes. During the logarithmic growth phase nearly 100% of P. mirabilis and P. vulgaris strains of various origin haemolyzed 100-50% of erythrocytes. Except for Serratia, the other representatives of Enterobacteriaceae did not demonstrate such activity in the same conditions. The preliminary characteristics of this phenomenon is given.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6202102

Source DB:  PubMed          Journal:  Acta Microbiol Pol        ISSN: 0137-1320


  7 in total

Review 1.  Potential virulence factors of Proteus bacilli.

Authors:  A Rózalski; Z Sidorczyk; K Kotełko
Journal:  Microbiol Mol Biol Rev       Date:  1997-03       Impact factor: 11.056

2.  Characterization of cell-bound and cell-free hemolytic activity of Proteus strains.

Authors:  W Kaca; A Rózalski
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

Review 3.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

4.  The HpmA hemolysin is more common than HlyA among Proteus isolates.

Authors:  K G Swihart; R A Welch
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Hemolytic activity and invasiveness in strains of Proteus penneri.

Authors:  A Rozalski; K Kotełko
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

6.  Vaccination with proteus toxic agglutinin, a hemolysin-independent cytotoxin in vivo, protects against Proteus mirabilis urinary tract infection.

Authors:  Praveen Alamuri; Kathryn A Eaton; Stephanie D Himpsl; Sara N Smith; Harry L T Mobley
Journal:  Infect Immun       Date:  2008-11-24       Impact factor: 3.441

7.  Professor Krystyna Kotełko and her contribution to the study of Proteus endotoxin.

Authors:  Antoni W Różalski
Journal:  Innate Immun       Date:  2018-04       Impact factor: 2.680

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.